BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30170289)

  • 1. Development and modeling of two-dimensional fast protein liquid chromatography for producing nonstructural protein-free food-and-mouth diseases virus vaccine.
    Bagheri M; Norouzi HR; Hossienizadeh SMJ; Es-Haghi A; Ghassempour A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1096():113-121. PubMed ID: 30170289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Dimensional Anion Exchange-Size Exclusion Chromatography Combined with Mathematical Modeling for Downstream Processing of Foot and Mouth Disease Vaccine.
    Hossienizadeh SMJ; Bagheri M; Alizadeh M; Rahimi M; Azimi SM; Kamalzade M; Es-Haghi A; Ghassempour A
    J Chromatogr A; 2021 Apr; 1643():462070. PubMed ID: 33773416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hydrophobic interaction chromatography strategy for purification of inactivated foot-and-mouth disease virus.
    Li H; Yang Y; Zhang Y; Zhang S; Zhao Q; Zhu Y; Zou X; Yu M; Ma G; Su Z
    Protein Expr Purif; 2015 Sep; 113():23-9. PubMed ID: 25957800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size exclusion chromatography using large pore size media induces adverse conformational changes of inactivated foot-and-mouth disease virus particles.
    Song Y; Yang Y; Lin X; Zhao Q; Su Z; Ma G; Zhang S
    J Chromatogr A; 2022 Aug; 1677():463301. PubMed ID: 35809520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Using size-exclusion chromatography to quantify the 146S antigen in inactivated foot-and-mouth disease vaccine].
    Xu Y; Zou X; Li C; Zhu Y; He T; Yang Y; Lin X; Song Y; Zheng J; Zhang S; Zhao Q
    Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):676-684. PubMed ID: 29893075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foot and mouth disease (FMD) virus: quantification of whole virus particles during the vaccine manufacturing process by size exclusion chromatography.
    Spitteler MA; Fernández I; Schabes E; Krimer A; Régulier EG; Guinzburg M; Smitsaart E; Levy MS
    Vaccine; 2011 Sep; 29(41):7182-7. PubMed ID: 21651939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marker vaccine potential of foot-and-mouth disease virus with large deletion in the non-structural proteins 3A and 3B.
    Biswal JK; Subramaniam S; Ranjan R; Sharma GK; Misri J; Pattnaik B
    Biologicals; 2015 Nov; 43(6):504-11. PubMed ID: 26260689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing.
    Spitteler MA; Romo A; Magi N; Seo MG; Yun SJ; Barroumeres F; Régulier EG; Bellinzoni R
    Vaccine; 2019 Aug; 37(36):5288-5296. PubMed ID: 31353259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals.
    Lu Z; Cao Y; Guo J; Qi S; Li D; Zhang Q; Ma J; Chang H; Liu Z; Liu X; Xie Q
    Vet Microbiol; 2007 Nov; 125(1-2):157-69. PubMed ID: 17601688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of bio-macromolecule denaturation on solid-liquid surface of ion-exchange chromatographic media - A case study for inactivated foot-and-mouth disease virus.
    Yang Y; Song Y; Lin X; Li S; Li Z; Zhao Q; Ma G; Zhang S; Su Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Apr; 1142():122051. PubMed ID: 32145639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size-exclusion HPLC provides a simple, rapid, and versatile alternative method for quality control of vaccines by characterizing the assembly of antigens.
    Yang Y; Li H; Li Z; Zhang Y; Zhang S; Chen Y; Yu M; Ma G; Su Z
    Vaccine; 2015 Feb; 33(9):1143-50. PubMed ID: 25604799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of foot and mouth disease virus nonstructural polyprotein 3AB-coding region to design a negative marker virus.
    Bhatt M; Mohapatra JK; Pandey LK; Mohanty NN; Das B; Prusty BR; Pattnaik B
    Virus Res; 2018 Jan; 243():36-43. PubMed ID: 29037477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a bio-analytical strategy for characterization of vaccine particles combining SEC and nanoES GEMMA.
    Havlik M; Marchetti-Deschmann M; Friedbacher G; Messner P; Winkler W; Perez-Burgos L; Tauer C; Allmaier G
    Analyst; 2014 Mar; 139(6):1412-9. PubMed ID: 24473104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Characterization of the Viroporin Function of Foot-and-Mouth Disease Virus Nonstructural Protein 2B.
    Gladue DP; Largo E; de la Arada I; Aguilella VM; Alcaraz A; Arrondo JLR; Holinka LG; Brocchi E; Ramirez-Medina E; Vuono EA; Berggren KA; Carrillo C; Nieva JL; Borca MV
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of foot-and-mouth disease virus by heparin as ligand for certain strains.
    Du P; Sun S; Dong J; Zhi X; Chang Y; Teng Z; Guo H; Liu Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1049-1050():16-23. PubMed ID: 28260627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism and inhibition of abnormal chromatographic behavior of serotype type a inactivated foot and mouth disease virus in high-performance size-exclusion chromatography.
    Yang Y; Li M; Zhao Y; Lin X; Su Z; Xin F; Du X; Zheng K; Han R; Pan Y; He S; Zhang S
    J Chromatogr A; 2022 Dec; 1686():463648. PubMed ID: 36410170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot-and-mouth disease vaccines: progress and problems.
    Cao Y; Lu Z; Liu Z
    Expert Rev Vaccines; 2016 Jun; 15(6):783-9. PubMed ID: 26760264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carboxy-terminal half of nonstructural protein 3A is not essential for foot-and-mouth disease virus replication in cultured cell lines.
    Behura M; Mohapatra JK; Pandey LK; Das B; Bhatt M; Subramaniam S; Pattnaik B
    Arch Virol; 2016 May; 161(5):1295-305. PubMed ID: 26935917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.